PDK1 and pachyonychia congenita: After treatment with entrectinib, the expression of STAMBP, E2F1, and PDK1 was decreased in drug-resistant PC cells (Fig. 8H and Fig. 6E), and PC cells exhibited a remarkable increase in sensitivity to GEM (Fig. 8I and Supplementary Fig. S7F, G).